A Comparative Study: the Efficacy of Liquid Paraffin and Lactulose in Management of Chronic Functional Constipation
Overview
Affiliations
Objectives: To determine and compare efficacy, safety and optimal dose of two laxatives, liquid paraffin and lactulose, in 40 children with chronic functional constipation.
Methods: A total of 20 children were treated with liquid paraffin and 20 with lactulose for 8 weeks and at an initial dose of 1 mL/kg per day for both drugs. The dose was adjusted every 3 days as required and a diary was kept to monitor dose, side-effects, stool frequency and consistency, and other symptoms.
Results: During first 4 weeks, improvement in stool consistency and frequency was significantly higher in liquid the paraffin group (P < 0.01 and P < 0.05, respectively). Improvement in the number of stools per week was also significantly higher in the liquid paraffin group during the last 4 weeks of therapy (P < 0.05). Compliance rates averaged 95% in the liquid paraffin group and 90% in the lactulose group during the first 4 weeks of therapy and 90% in the liquid paraffin group and 60% in the lactulose group during the last 4 weeks of therapy (chi(2) = 4.8, SD = 1, P = 0.02). During the first 4 weeks of therapy and during the last 4 weeks of therapy, mostly side-effects and poor symptom control, respectively, influenced the compliance in the liquid paraffin group.
Conclusions: Liquid paraffin is more effective in the treatment of children with constipation. Patients treated with liquid paraffin responded more rapidly than patients responding to lactulose and showed fewer side-effect. It is considered that late response and side-effects in conjunction with poor symptom control influence the patient compliance and the successful treatment of childhood constipation.
Strategies used for childhood chronic functional constipation: the SUCCESS evidence synthesis.
Todhunter-Brown A, Booth L, Campbell P, Cheer B, Cowie J, Elders A Health Technol Assess. 2024; 28(5):1-266.
PMID: 38343084 PMC: 11017632. DOI: 10.3310/PLTR9622.
Utrilla Fornals A, Costas-Batlle C, Medlin S, Menjon-Lajusticia E, Cisneros-Gonzalez J, Saura-Carmona P Nutrients. 2024; 16(2).
PMID: 38257141 PMC: 10820062. DOI: 10.3390/nu16020246.
An Update of Pharmacological Management in Children with Functional Constipation.
de Geus A, Koppen I, Flint R, Benninga M, Tabbers M Paediatr Drugs. 2023; 25(3):343-358.
PMID: 36941393 PMC: 10097737. DOI: 10.1007/s40272-023-00563-0.
Functional constipation in children: What physicians should know.
Tran D, Sintusek P World J Gastroenterol. 2023; 29(8):1261-1288.
PMID: 36925458 PMC: 10011959. DOI: 10.3748/wjg.v29.i8.1261.
Childhood constipation: Current status, challenges, and future perspectives.
Rajindrajith S, Devanarayana N, Benninga M World J Clin Pediatr. 2022; 11(5):385-404.
PMID: 36185096 PMC: 9516492. DOI: 10.5409/wjcp.v11.i5.385.